Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
Nature Medicine2015Vol. 21(6), pp. 601–609
Citations Over TimeTop 10% of 2015 papers
Mario Schiffer, Beina Teng, Changkyu Gu, Valentina A. Shchedrina, Marina V. Kasaikina, Vincent A. Pham, Nils Hanke, Song Rong, Faikah Gueler, Patricia Schröder, Irini Tossidou, Joon-Keun Park, Lynne Staggs, Hermann Haller, Sergej Erschow, Denise Hilfiker‐Kleiner, Changli Wei, Chuang Chen, Nicholas J. Tardi, Samy Hakroush, Martin K. Selig, Aleksandr Vasilyev, Sandra Merscher, Jochen Reiser, Sanja Sever
Related Papers
- → Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis(2011)259 cited
- → Podocytopathy: The role of actin cytoskeleton(2022)43 cited
- → Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease(2016)70 cited
- → The podocyte cytoskeleton in health and in disease(2012)21 cited
- → Foothold of NPHS2 mutations in primary nephrotic syndrome(2011)8 cited